Literature DB >> 3023486

BSF1 induces membrane protein phosphorylation but not phosphoinositide metabolism, Ca2+ mobilization, protein kinase C translocation, or membrane depolarization in resting murine B lymphocytes.

L Justement, Z Chen, L Harris, J Ransom, V Sandoval, C Smith, D Rennick, N Roehm, J Cambier.   

Abstract

The findings presented in this study provide evidence that BSF1 receptors and mIg transmit signals via dissimilar transduction mechanisms that result in a common biologic response, hyper-Ia expression. Specifically, BSF1-containing supernatant does not induce PtdInsP2 hydrolysis as determined by measurement of PtdOH and InsP3. Additionally, BSF1 does not stimulate Ca2+ mobilization, PKC translocation from cytosol to membrane, or membrane depolarization. All of these metabolic events appear to play a central role in hyper-Ia expression mediated by mIg and are initiated after treatment of resting B cells with anti-Ig antibodies. In vitro phosphorylation studies with partially purified plasma membranes from resting B cells revealed that BSF1 interaction with membrane receptors stimulates a membrane-associated protein kinase that phosphorylates an endogenous protein of 44 KDa. Anti-Ig does not stimulate phosphorylation of the 44 KDa protein, suggesting that it does not activate the membrane-associated protein kinase. This observation provides the first evidence of a signal transduction mechanism associated with BSF1-receptor ligation. It indicates that although BSF1 does not modulate events associated with PKC activation, it may function via activation of a membrane-associated protein kinase. This provides a focal point for further studies directed at elucidating signal transduction resulting from BSF1-receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023486

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  A microfilament formation inhibitor, cytochalasin strongly enhances the low-affinity Fc epsilon receptor II (CD23) expression on the human monocyte-like cell line, U937.

Authors:  N Ikewaki; H Tamauchi; A Yamada; M Aoki; R Yamamoto; A Sawada; H Inoko
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

2.  Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4.

Authors:  J G Shields; R J Armitage; B N Jamieson; P C Beverley; R E Callard
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

3.  Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.

Authors:  D Wang; D Liebowitz; F Wang; C Gregory; A Rickinson; R Larson; T Springer; E Kieff
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

4.  B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation.

Authors:  A O'Garra; K P Rigley; M Holman; J B McLaughlin; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  Defective HLA class II expression in a regulatory mutant is partially complemented by activated ras oncogenes.

Authors:  C R Hume; R S Accolla; J S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding.

Authors:  N Harada; B E Castle; D M Gorman; N Itoh; J Schreurs; R L Barrett; M Howard; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Endogenously secreted IL-4 is required for mouse thymocytes to become cytotoxic. Human, but not mouse, IL-2 induces a functionally immature thymic subset to secrete IL-4 and become CTL.

Authors:  K E Stedman; L B Justement; P A Campbell
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

8.  Differential STIM1 expression in T and B cell subsets suggests a role in determining antigen receptor signal amplitude.

Authors:  Yuval Yarkoni; John C Cambier
Journal:  Mol Immunol       Date:  2011-06-12       Impact factor: 4.407

9.  Ligand-stimulated tyrosine phosphorylation of the IL-2 receptor beta chain and receptor-associated proteins.

Authors:  D A Shackelford; I S Trowbridge
Journal:  Cell Regul       Date:  1991-01

10.  Involvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.

Authors:  J Y Blay; D Branellec; E Robinet; B Dugas; F Gay; S Chouaïb
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.